Neuropace Entered Collaboration With Rapport Therapeutics To Share Site Data For Rapport's Phase 2a Trial Of Their Gama 8 Receptor-associated Protein Compound.
Neuropace Entered Collaboration With Rapport Therapeutics To Share Site Data For Rapport's Phase 2a Trial Of Their Gama 8 Receptor-associated Protein Compound.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.